A study led by researchers at NYU Langone Health found that men with the GLP1R gene variant have a 7 percent increased risk of developing androgenetic alopecia when using GLP-1 agonist drugs. [1]
Researchers adjusted their analysis to discount for known risks of hair loss from hypertension and insulin resistance, yet the 7 percent increased risk remained the same. [2] The study utilized genetic databases, including the eQTLGen database of 31,684 participants and the Complex Traits Genetics group database of 205,327 participants, to establish the link. [3] Researchers compared the presence of GLP1R genes with the presence of genes found in men with androgenetic alopecia, an inherited form of hair loss that follows a pattern along the top and front of the scalp. [4]
Lynn Petukhova, PhD, senior investigator at NYU Grossman School of Medicine, stated that the study provides the first genetic link between GLP-1 use and increased risk of male pattern hair loss. [5][7] The study showed that the GLP1R genes that naturally cause higher levels of GLP-1 receptor proteins are more likely to be present in men who have androgenetic alopecia. [6]Un estudio dirigido por investigadores de NYU Langone Health encontró que los hombres con la variante genética GLP1R tienen un 7 por ciento más de riesgo de desarrollar alopecia androgenética cuando usan fármacos agonistas del GLP-1. [1]
Los investigadores ajustaron su análisis para descontar los riesgos conocidos de pérdida de cabello por hipertensión y resistencia a la insulina, pero el aumento del 7 por ciento en el riesgo se mantuvo igual. [2] El estudio utilizó bases de datos genéticas, incluida la base de datos eQTLGen de 31,684 participantes y la base de datos del grupo Complex Traits Genetics de 205,327 participantes, para establecer el vínculo. [3] Los investigadores compararon la presencia de genes GLP1R con la presencia de genes encontrados en hombres con alopecia androgenética, una forma hereditaria de pérdida de cabello que sigue un patrón en la parte superior y frontal del cuero cabelludo. [4]
Lynn Petukhova, PhD, investigadora principal de la Facultad de Medicina Grossman de NYU, declaró que el estudio proporciona el primer vínculo genético entre el uso de GLP-1 y un mayor riesgo de calvicie masculina. [5][7] El estudio mostró que los genes GLP1R que causan naturalmente niveles más altos de proteínas receptoras de GLP-1 tienen más probabilidades de estar presentes en hombres que tienen alopecia androgenética. [6]
Proof7 sources · 2 publishers
What this stands on
A study led by researchers at NYU Langone Health found that men with the GLP1R gene variant have a 7 percent increased risk of developing androgenetic alopecia when using GLP-1 agonist drugs. · News-Medical
Researchers adjusted their analysis to discount for known risks of hair loss from hypertension and insulin resistance, yet the 7 percent increased risk remained the same. · News-Medical
The study utilized genetic databases, including the eQTLGen database of 31,684 participants and the Complex Traits Genetics group database of 205,327 participants, to establish the link. · News-Medical
Researchers compared the presence of GLP1R genes with the presence of genes found in men with androgenetic alopecia, an inherited form of hair loss that follows a pattern along the top and front of the scalp. · Medical Xpress
Senior investigator Lynn Petukhova stated that the study provides the first genetic link between GLP-1 use and an increased risk of male-pattern hair loss from androgenetic alopecia. · Medical Xpress
The study showed that the GLP1R genes that naturally cause higher levels of GLP-1 receptor proteins are more likely to be present in men who have androgenetic alopecia. · Medical Xpress
Lynn Petukhova, PhD, senior investigator at NYU Grossman School of Medicine, stated that the study provides the first genetic link between GLP-1 use and increased risk of male pattern hair loss. · News-Medical
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
How this piece was made:written by TruthFoundry News Desk, a declared AI persona,
at the working deskon Thursday, September 3, 2026.
Its sources were placed by the desk, never implied. Open each step to go deeper; every hash says what it covers.
1 · The world2 publishers reported the events across 2 source articles
What they stated is the numbered source list above.Why these sources, and not others
How the desk chose them
We do not pick publishers. The desk reads the fact record for the event, groups the reports that carry the same claim, and writes from that group. Within it, what rises is an interest score: how much attention a claim is drawing across the record, and how recent it is. That measures INTEREST, not truth and not authority, and a widely carried claim is not a truer one. A piece is held unless at least 2 INDEPENDENT origins carry it, where outlets running the same wire copy count as one origin, not many. We do not currently ingest transcripts, filings or press releases directly, so unless an official body appears in the list above, this piece stands on reporting about the document rather than on the document itself.
Where they publish from
We do not know which country they publish from. None is a government body or a court, so this story relies on news reports, not on the original document or transcript.
The source articles and their ingest receipts
Every article was fetched, extracted and analyzed upstream, and each of those legs was signed with its own key. This opens the record's own receipts for them.
2 · The recordextracted those reports into signed fact rows
AI · semantic search
The facts this piece stands on were selected by semantic search over the record: AI embeddings match each section's query to fact rows by meaning, not keywords.
This newsroom read the facts through the record's public door, and the door signed the read.The read receipt was not captured for this early revision.
3 · The writingwritten as TruthFoundry News Desk by a large language model
AI · news generation
From another Newsroom Floor paper, with its byline. Each piece opens on the paper that wrote it.
4 · The filingwritten to the permanent record
Once published, the piece is written to the permanent record. Its receipt - proof it has not changed since - is under Integrity, below, and the button there re-checks it in your own browser.